Kayla is an Australian-qualified associate in the Private Equity group.
She advises private equity houses, and their portfolio companies and management teams, on UK and cross-border acquisitions, disposals and restructurings across a range of industry sectors. Kayla also advises corporate clients on mergers & acquisitions and general corporate matters.
We have advised the CEO and management team of Synthon, a global pharmaceutical company focusing on generic drugs, on its sale by BC Partners to Goldman Sachs Alternatives (Goldman Sachs).
Press releaseWe have advised Sullivan Street Partners, a UK-based mid-market buy-out specialist, on its sale of grounds maintenance company Tivoli to the Nurture Group.
Press releaseWe have advised Sullivan Street Partners, a UK-based mid-market buy-out specialist, on its acquisition of UK Addiction Treatment Group (UKAT), the UK’s leading, residential addiction treatment group.
Press releaseWe have advised Coherent Corp., the global leader in materials, networking, and lasers, on selling its manufacturing site in Newton Aycliffe, County Durham, UK to the UK Government.
Press releaseWe have advised Inflexion on its investment into FDMUK Limited, a provider of telecoms market share, pricing and proposition data across Europe.
Press releaseWe have advised the management team of Chambers and Partners on the sale of Inflexion's investment in the firm to Abry Partners, a leading middle market private equity firm headquartered in North America.
Press releasepar plusieurs auteurs
Taylor Wessing advises in Inflexion's £400 million sale of Chambers to Abry Partners
par plusieurs auteurs
Advising Bridgepoint on fscom investment
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par Emma Danks et Dr. Christian Traichel
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par Debbie Cloake
par Lorraine Smith